Bacterial fatty-acid biosynthesis: an antibacterial drug target waiting to be exploited
- 3 July 2001
- journal article
- editorial
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (14) , 715
- https://doi.org/10.1016/s1359-6446(01)01881-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lipid biosynthesis as a target for antibacterial agentsProgress in Lipid Research, 2001
- Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discoveryDrug Discovery Today, 2001
- Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and CeruleninJournal of Biological Chemistry, 2001
- Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparumNature Medicine, 2001
- The Enoyl-[acyl-carrier-protein] Reductases FabI and FabL fromBacillus subtilisJournal of Biological Chemistry, 2000
- Erratum: A triclosan-resistant bacterial enzymeNature, 2000
- Nuclear-encoded proteins target to the plastid inToxoplasma gondiiandPlasmodium falciparumProceedings of the National Academy of Sciences, 1998